Hy-Vee rolls out GLP-1 wellness program, offers free enrollment to first 1,000 sign-ups
The program follows the recent launch of Medicare’s new GLP-1 Bridge program.
The program follows the recent launch of Medicare’s new GLP-1 Bridge program.
New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidence
The only privately owned building on the National Mall invites visitors inside as part of America's 250th anniversary celebration.
Once completed, the new Maxi and Pharmaprix (Shoppers Drug Mart) will create approximately 95 jobs and help strengthen the region's retail and healthcare offerings.
Matt will be responsible for driving the global strategy, performance and growth of the Pharmacy Automation business, as part of the Connected Care segment.
Diagnosed at a time when HIV was often considered a terminal condition, CVS Specialty patient Christopher Hooper is now living a full life decades later, reflecting the impact of modern treatment.
Represents the Company’s 29th product launch since inception in October 2023.
The Annual Report on Form 20-F is also available on Dr. Reddy’s website.
Liquid formulation enhances treatment flexibility.
The event highlighted emerging technologies such as artificial intelligence (AI), with opportunities for attendees to participate in tech-focused education, explore new tools and experience hands-on interactions with AI-powered solutions for their pharmacies.
Industry leaders will gather in the Washington D.C. metro area next June.
New initiative expands access to trusted information, pharmacy support, and healthcare navigation resources for Medicare beneficiaries as Medicare GLP-1 Bridge program launches.
Eligible Medicare patients can access support through a new $50 monthly copay, including one-on-one pharmacist guidance and over-the-counter products to help manage common side effects.
The chain will also offer a 20% in‑store discount to veterans, active‑duty service members, and their immediate families.
In comments to the agency, NACDS calls for reforms that work within real-world pharmacy workflows — reducing the administrative burdens that delay patients' access to their medications.
Nitazoxanide Tablets are antiprotozoal indicated for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum.